Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 82009-033

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 82009-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 01)

Chemical structure diagram depicting the active ingredient Esomeprazole Magnesium, showing the molecular components and arrangement including magnesium with three water molecules.*

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 02)

A line graph showing percent maintained over six months for Esomeprazole Magnesium Delayed-Release Capsules 40 mg at three different sample sizes and a placebo group. The y-axis represents percent maintained from 0 to 100, and the x-axis represents time in months from 0 to 6. The graph depicts treatment effectiveness over time comparing active capsules versus placebo.*

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 03)

A line graph displaying the percentage maintained over a 6-month period for different doses of Esomeprazole Magnesium Delayed-Release Capsules (10 mg, 20 mg, 40 mg) compared to placebo. The x-axis represents months, and the y-axis shows the percent maintained. Each dose group and placebo are represented by distinct lines, with a legend indicating sample sizes for each group.*

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 04)

A line graph showing the percent of patients symptom-free over a 28-day diary period for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The vertical axis ranges from 0 to 100 percent, and the horizontal axis shows diary days from 0 to 28. Both Esomeprazole groups show higher symptom-free percentages compared to placebo throughout the period.*

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 05)

A line graph showing the percent of patients symptom-free over a 28-day diary period, comparing Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg strengths versus placebo. The vertical axis represents the percent of patients symptom-free, and the horizontal axis represents the diary days up to 28 days.*

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 06)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP, 20 mg strength. The label indicates the product is Rx only, contains 1,000 capsules, and is manufactured for Quallent Pharmaceuticals Health LLC. The label includes storage instructions and a barcode. The label specifies it is a bulk package not intended for dispensing.*

FDA Label Image

Image (4d5b2adb 336f 4b09 9543 Bc8a35edb544 07)

Label for Esomeprazole Magnesium Delayed-Release Capsules USP, 40 mg strength. The label indicates an oral dosage form, 90 capsules per package, and is manufactured by Quallent Pharmaceuticals Health LLC. It includes storage instructions and a barcode. The package is labeled Rx only and highlights the magnesium trihydrate equivalent of 40 mg esomeprazole. The branding includes the Quallent Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.